Lü, Tie-Ming <br/><br/>
Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.  [electronic resource] 

 -  Chinese medical journal  Mar 2011 
 - 664-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2542-5641 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alemtuzumab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--therapeutic use<br/>Antilymphocyte Serum--therapeutic use<br/>Female<br/>Graft Rejection--immunology<br/>Graft Survival--immunology<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Treatment Outcome<br/>Young Adult